The alarming rate of obesity and weight gain in industrialized nations is one of the most concerning health issues plaguing developed countries today. Scientists might have just come much closer to finally ending this epidemic by preventing mice from gaining weight even with a steady diet of high-fat food. Could these findings lead to effortless weight loss?
Published on eLife, the study described how scientists from Washington University School of Medicine basically activated certain pathways in fat cells, which essentially allowed the mice to go on a high-fat diet without becoming obese. This could lead to some huge leaps in treating all the other diseases that are associated with weight gain, including type-2 diabetes.
“Here by inducing expression of constitutively active Smoothened (SmoM2) or Gli2 (ΔNGli2) in the adipocyte lineage of postnatal mice, we show that targeted activation of Hh signaling suppresses high-fat-diet-induced obesity and improves whole-body glucose tolerance and insulin sensitivity,” the study reads.
As senior investigator Fanxin Long, Ph.D. put it, these findings could lead to new ways to treat the growing obesity epidemic afflicting populations even in developing countries. It also makes preventing weight gain easier because it targets the root cause of the issue.
"This could lead us to a new therapeutic target for treating obesity," Long said. "What's particularly important is that the animals in our study ate a high-fat diet but didn't gain weight, and in people, too much fat in the diet is a common cause of obesity."
On that note, translating the results of this study to apply to humans might not be that easy, MedicalXpress reports. The test subjects and people don’t exactly have the same metabolism and the methods used to activate the pathways in fat cells to stop them from growing might cause unknown side-effects. It might even cause cancer if the application is not done properly.


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 



